Phoenix Life Sciences International Limited. Selling Expense
Phoenix Life Sciences International Limited. reported Selling Expense of $124.26 thousand for the 12-month period ending 2019-02-28, per its 10-K filed 2020-04-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2020-04-10
- Phoenix Life Sciences International Limited. selling expense for fiscal 2019 was $124.26K.
- Phoenix Life Sciences International Limited. selling expense for fiscal 2018 was $0.00.
| Period end | Selling Expense 12 month |
|---|---|
| 2019-02-28 | $124.26K 10-K · filed 2020-04-10 |
| 2018-02-28 | $0.00 10-K · filed 2020-04-10 |